Interestingly, when we examined data from a previously published prostate cancer cohort (Li et al., 2020), we found that AR expression negatively correlated with the expression of CDKN2B-AS1 in the normal prostate, and this correlation was completely dependent on the reference allele, but not the risk allele. Here, CDKN2B is linked to Familial prostate cancer.